Sage Journals: Discover world-class research

Retricted access

Case report

First published 2025-10

Management and desensitization to Avelumab in anaphylaxis and metastatic urothelial carcinoma: A case report

Rosalaura Villarreal-González, Ana Karen Treviño-Morales, Diana Cadenas-García [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2019

A review of avelumab in locally advanced and metastatic bladder cancer

Arpit Rao, Manish R. Patel

Therapeutic Advances in Urology

Retricted access

Review article

First published 2018-9

Avelumab: A Review of Its Application in Metastatic Merkel Cell Carcinoma

Jocelyn Joseph, Chrystia Zobniw, Jennifer Davis [...]

Annals of Pharmacotherapy

Open access

Research article

First published 2025-1

Platinum-based chemotherapy rechallenge or enfortumab vedotin after maintenance avelumab or pembrolizumab for locally advanced or metastatic urothelial carcinoma

Nobutaka Nishimura, Makito Miyake, Norimi Takamatsu [...]

Bladder Cancer

Open access

Research article

First published 2019

Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody,Avelumab

Elaine M. Jagoda, Olga Vasalatiy, Falguni Basuli [...]

Molecular Imaging

Open access

Research article

First published 2025

Xevinapant plus avelumab in advanced solid tumours,with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker,safety and efficacy analyses from an open-label,nonrandomised phase Ib study

Glenwood Goss, Tudor Ciuleanu, Rodryg Ramlau [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2017-7

Drug Monographs: Avelumab and Ribociclib

J. Aubrey Waddell, Dominic A. Solimando

Hospital Pharmacy

Open access

Review article

First published 2023

The role of switch maintenance therapy in urothelial cancers

Eun-mi Yu, Mythri Mudireddy, Rakesh Biswas [...]

Therapeutic Advances in Urology

Retricted access

Article commentary

First published 2019-1

Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?

Constantin A Dasanu, Michael Del Rosario, Ion Codreanu [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2018-1

The Emerging Role of PD-1/PD-L1–Targeting Immunotherapy in the Treatment of Metastatic Urothelial Carcinoma

Morgan E. Gwynn, David L. DeRemer

Annals of Pharmacotherapy

Search results